Zehu Sheng

Jan 2, 2025 | alzres.biomedcentral.com | Zehu Sheng |Lanyang Wang |Ming Chen |Fuxin Zhong |Shijing Wu |Shuyu Liang | +6 more

All data were from the ADNI database (https://adni.loni.usc.edu). The goal of the ADNI project is to identify biochemical, genetic, imaging, and clinical biomarkers that may be used to predict the early beginning of AD. Participants have been recruited from more than 50 sites in the US and Canada [24]. We included 211 individuals providing clinical conditions, CSF and plasma β2M, CSF GFAP, sTREM2, and AD biomarkers.

Jul 12, 2024 | nature.com | Zehu Sheng

AbstractThe relationship between the triglyceride glucose-body mass index (TyG-BMI) index and Alzheimer’s disease (AD) pathology, cognition, and brain structure remains unclear. This study aimed to investigate these associations, focusing on cerebrospinal fluid (CSF) biomarkers, cognitive measures, and brain imaging data. Eight hundred and fifty-five non-demented participants were included.